Drugs News and Research

RSS

Rheumatoid arthritis patients taking opioids have twice the risk of venous thromboembolism

New research presented this week at ACR Convergence 2022, the American College of Rheumatology's annual meeting, found that adult RA patients starting opioids had twice the risk of venous thromboembolism (VTE) compared to patients starting nonsteroidal anti-inflammatory drugs (NSAIDs).

8 Nov 2022

New research helps understand how breathing shapes our brain

"Breathe in… Breathe out…" Or: "take a deep breath and count to ten." The calming effect of breathing in stressful situations, is a concept most of us have met before.

8 Nov 2022

Scientists develop new electrochemical sensing platform to monitor vascularized tissue model

The costliness of drug development and the limitations of studying physiological processes in the lab are two separate scientific issues that may share the same solution.

8 Nov 2022

Cancer drugs work better after vaccination with the Chinese Covid vaccine

Patients with nasopharyngeal cancer are often treated with drugs that activate their immune system against the tumor.

8 Nov 2022

Defense department health plan cuts its pharmacy network by nearly 15,000 outlets

Doris Spatz takes a once-a-day pill, Kisqali, to keep her metastatic breast cancer in check. As a patient in the Defense Department health system, she can fill routine prescriptions at a military pharmacy without a copay but also has the option of using a regular pharmacy through Tricare, the Defense Department's private health care program.

8 Nov 2022

Researchers unravel genetic changes in a region that controls the activity of the genome

Scientists have discovered the cause of a rare condition within a part of the genome that has been largely unexplored in medical genetics. A team at the University of Exeter has found genetic changes in a region that controls the activity of the genome, turning on or off genes, and in doing so they have found a key that could unlock other causes of rare conditions.

8 Nov 2022

Study identifies a potential pharmacological target for treating COVID-19-associated heart failure

Researchers at the University of Maryland School of Medicine's (UMSOM) Center for Precision Disease Modeling identified how a specific protein in SARS-CoV-2, the virus responsible for COVID-19, damages heart tissue. They then used a drug to reverse the toxic effects of that protein on the heart.

8 Nov 2022

Study: Fenofibrate not a useful strategy for decreasing COVID-19 severity

After showing promise in early laboratory research, the cholesterol-lowering drug fenofibrate had no significant effect on COVID-19 outcomes in a multicenter international randomized clinical trial led by Penn Medicine scientists.

8 Nov 2022

SGLT-2 inhibitors reduce cardiovascular risk among patients with chronic kidney disease

SGLT-2 inhibitors, a type of diabetes medicine, decreased cardiovascular risk among adults with chronic kidney disease, according to late-breaking research presented today at the American Heart Association's Scientific Sessions 2022.

7 Nov 2022

National study sheds light on how to more effectively treat atrial fibrillation

A national study led by UBC researchers at the Centre for Cardiovascular Innovation is shedding light on how to more effectively treat atrial fibrillation (AF) – a common heart rhythm problem associated with increased risk of stroke and heart failure.

7 Nov 2022

Study uncovers a previously unknown propofol effect in neurons

Propofol is the most commonly used drug to induce general anesthesia. Despite its frequent clinical application, it is poorly understood how propofol causes anesthesia.

7 Nov 2022

Rosuvastatin vastly superior to six common heart health supplements

Six widely used dietary supplements often advertised to promote heart health are actually ineffective at lowering cholesterol levels.

7 Nov 2022

Personalized whole genome sequencing approach could double the diagnostic rates of rare diseases

Tailoring the analysis of whole genome sequencing to individual patients could double the diagnostic rates of rare diseases, finds a new study led by UCL researchers.

7 Nov 2022

Supreme Court to hear nursing home case that could affect millions

When Susie Talevski sued the agency that managed her elderly father's care before he died, she hoped to get justice for her family.

7 Nov 2022

Beyond vaccines: emerging technologies capable of unlocking the promise of biologically targeted mRNA therapeutics

Researchers reviewed technology advancements that will unlock the promise of biologically targeted messenger ribonucleic acid (mRNA) therapeutics beyond vaccines.

7 Nov 2022

Cannabis, cocaine, methamphetamine, and opiates increase risk of atrial fibrillation

A recent study published in the European Heart Journal reveals that using illicit drugs can increase atrial fibrillation risk.

6 Nov 2022

Novel drug lowers triglycerides, does not reduce cardiovascular events

Levels of triglycerides are routinely measured as part of a preventive cardiology work-up and lowering triglycerides with several classes of drugs is common medical practice.

6 Nov 2022

New mathematical model could aid in assessing different approaches for treating metastatic cancer

A Rochester Institute of Technology scientist helped develop a new mathematical model that could aid doctors and patients assessing different approaches for treating metastatic cancer.

4 Nov 2022

Anti-herpes drug can fight against antibiotic-resistant bacterium

A UNIGE team reveals that a drug used against herpes can fight a bacterium that is resistant to most antibiotics by weakening its defense mechanisms.

4 Nov 2022

Blood pressure drug associated with lower risk of Alzheimer's disease in Black patients

Considering how patients from different ethnic groups respond to the same drug could be crucial to finding new Alzheimer's disease treatments – a disorder the Alzheimer's Association previously deemed a "silent epidemic" among Black adults.

4 Nov 2022

Drugs News and Research

Rheumatoid arthritis patients taking opioids have twice the risk of venous thromboembolism

New research helps understand how breathing shapes our brain

Scientists develop new electrochemical sensing platform to monitor vascularized tissue model

Cancer drugs work better after vaccination with the Chinese Covid vaccine

Defense department health plan cuts its pharmacy network by nearly 15,000 outlets

Researchers unravel genetic changes in a region that controls the activity of the genome

Study identifies a potential pharmacological target for treating COVID-19-associated heart failure

Study: Fenofibrate not a useful strategy for decreasing COVID-19 severity

SGLT-2 inhibitors reduce cardiovascular risk among patients with chronic kidney disease

National study sheds light on how to more effectively treat atrial fibrillation

Study uncovers a previously unknown propofol effect in neurons

Rosuvastatin vastly superior to six common heart health supplements

Personalized whole genome sequencing approach could double the diagnostic rates of rare diseases

Supreme Court to hear nursing home case that could affect millions

Beyond vaccines: emerging technologies capable of unlocking the promise of biologically targeted mRNA therapeutics

Cannabis, cocaine, methamphetamine, and opiates increase risk of atrial fibrillation

Novel drug lowers triglycerides, does not reduce cardiovascular events

New mathematical model could aid in assessing different approaches for treating metastatic cancer

Anti-herpes drug can fight against antibiotic-resistant bacterium

Blood pressure drug associated with lower risk of Alzheimer's disease in Black patients

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News